Shobha Kantamneni

Array ( [id] => 5297254 [patent_doc_number] => 20090012180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Titration of Tapentadol' [patent_app_type] => utility [patent_app_number] => 12/106695 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17396 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012180.pdf [firstpage_image] =>[orig_patent_app_number] => 12106695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10154588 [patent_doc_number] => 09186340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Ischemia/reperfusion protection compositions and methods of using' [patent_app_type] => utility [patent_app_number] => 12/595586 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 16353 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664173 [patent_doc_number] => 20080255080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Hydroquinone Ansamycin Formulations' [patent_app_type] => utility [patent_app_number] => 12/101473 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8415 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255080.pdf [firstpage_image] =>[orig_patent_app_number] => 12101473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772500 [patent_doc_number] => 08426455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Prophylactic and/or therapeutic agent for hyperlipidemia' [patent_app_type] => utility [patent_app_number] => 12/593356 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10025 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892944 [patent_doc_number] => 08916558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Powders for reconstitution' [patent_app_type] => utility [patent_app_number] => 12/530665 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8012 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12530665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644688 [patent_doc_number] => 20100227865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Oligomer-Beta Blocker Conjugates' [patent_app_type] => utility [patent_app_number] => 12/530412 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18745 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227865.pdf [firstpage_image] =>[orig_patent_app_number] => 12530412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820624 [patent_doc_number] => 20080226684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS' [patent_app_type] => utility [patent_app_number] => 12/047309 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25340 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226684.pdf [firstpage_image] =>[orig_patent_app_number] => 12047309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309828 [patent_doc_number] => 20090017109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'METHOD OF REDUCING SOMNOLENCE IN PATIENTS TREATED WITH TIZANIDINE' [patent_app_type] => utility [patent_app_number] => 12/046144 [patent_app_country] => US [patent_app_date] => 2008-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6338 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017109.pdf [firstpage_image] =>[orig_patent_app_number] => 12046144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6508809 [patent_doc_number] => 20100210654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'NOVEL P2Y12 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/530228 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24232 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210654.pdf [firstpage_image] =>[orig_patent_app_number] => 12530228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497817 [patent_doc_number] => 20100094001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'COMPOSITION CONTAINING STABILITY-IMPROVED CHLOROMETHYL PHOSPHATE DERIVATIVE AND PROCESS FOR PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 12/526905 [patent_app_country] => US [patent_app_date] => 2008-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6878 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20100094001.pdf [firstpage_image] =>[orig_patent_app_number] => 12526905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617295 [patent_doc_number] => 20100324019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Use of Riboflavin in the Treatment of Hypertension' [patent_app_type] => utility [patent_app_number] => 12/528105 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4963 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324019.pdf [firstpage_image] =>[orig_patent_app_number] => 12528105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786167 [patent_doc_number] => 20080139496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'COMBINATION THERAPY FOR REDUCTION OF TOXICITY OF CHEMOTHERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/034289 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10603 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139496.pdf [firstpage_image] =>[orig_patent_app_number] => 12034289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479061 [patent_doc_number] => 20100041703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'RAPID DISINTEGRATION MONOLAYER FILM FOR THE ORAL ADMINISTRATION OF ACTIVE SUBSTANCES' [patent_app_type] => utility [patent_app_number] => 12/529118 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3757 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041703.pdf [firstpage_image] =>[orig_patent_app_number] => 12529118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894078 [patent_doc_number] => 20080103177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'NEW USE OF ILOPERIDONE' [patent_app_type] => utility [patent_app_number] => 11/962893 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 953 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103177.pdf [firstpage_image] =>[orig_patent_app_number] => 11962893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785050 [patent_doc_number] => 20080138379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Methods, treatments, and compositions for modulating Hedgehog pathways' [patent_app_type] => utility [patent_app_number] => 12/001869 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41925 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138379.pdf [firstpage_image] =>[orig_patent_app_number] => 12001869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086445 [patent_doc_number] => 08557874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Hemostatic material' [patent_app_type] => utility [patent_app_number] => 11/945018 [patent_app_country] => US [patent_app_date] => 2007-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9033 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11945018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64146 [patent_doc_number] => 07759386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Pharmaceutical compositions of estrogenic agents' [patent_app_type] => utility [patent_app_number] => 11/943269 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10307 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759386.pdf [firstpage_image] =>[orig_patent_app_number] => 11943269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606116 [patent_doc_number] => 20100063146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'METHOD FOR TREATING DISORDERS RELATED TO COMPLEMENT ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/514024 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4188 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063146.pdf [firstpage_image] =>[orig_patent_app_number] => 12514024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6475453 [patent_doc_number] => 20100284960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Dosage Forms and Co-Administration of Opioid Agonist and Opioid Antagonist' [patent_app_type] => utility [patent_app_number] => 12/445922 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8637 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284960.pdf [firstpage_image] =>[orig_patent_app_number] => 12445922 [rel_patent_id] =>[rel_patent_doc_number] =>)